目錄:愛必信（上海）生物科技有限公司>>生化試劑>>小分子化合物>> abs810006Staurosporine
| 參考價 | 965 |
參考價：￥ 965
5mg
CAS:62996-74-1 純度:>98 % 分子量:466.54 分子式:C28H26N4O3 供貨周期:現(xiàn)貨 規(guī)格:5mg 貨號:abs810006 應用領域:化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 主要用途:對其他的激酶PKA,PKG，S6K，CaMKII，等也顯示抑制活性。
>| 5mg | 965元 | 999mg可售 |
更新時間：2025-11-11 15:15:50瀏覽次數(shù)：997評價
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
| CAS | 62996-74-1 | 純度 | >98 % |
|---|---|---|---|
| 分子量 | 466.54 | 分子式 | C28H26N4O3 |
| 供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5mg |
| 貨號 | abs810006 | 應用領域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
| 主要用途 | 對其他的激酶PKA,PKG，S6K，CaMKII，等也顯示抑制活性。 |
| 產(chǎn)品描述 | |
| 描述 | Staurosporine是一種有效的PKC抑制劑，在無細胞試驗中作用于PKCα，PKCγ 和PKCη，IC50分別為2nM，5nM 和 4nM，對PKCδ(20nM)和PKCε(73nM作用較弱，對PKCζ (1086nM)的活性很低。同時 對其他的激酶PKA，PKG，S6K，CaMKII，等也顯示抑制活性。 |
| 純度 | >98 % |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 星形孢菌素，Antibiotic AM-2282; STS; AM-2282;CGP 41251 |
| 外觀 | Lyophilized powder |
| 可溶性/溶解性 | DMSO：4 mg/mL (8.57 mM) |
| 生物活性 | |
| 靶點 | PKCα,c-Fgr,phosphorylase kinase,PKCη,PKCγ… |
| In vitro(體外研究) | Staurosporine, a microbial alkaloid, significantly inhibits protein kinase C from rat brain with IC50 of 2.7 nM. Staurosporine displays strong inhibitory effect against HeLa S3 cells with IC50 of 4 nM. Staurosporine also inhibits a variety of other protein kinases, including PKA, PKG, phosphorylase kinase, S6 kinase, Myosin light chain kinase (MLCK), CAM PKII, cdc2, v-Src, Lyn, c-Fgr, and Syk with IC50 of 15 nM, 18 nM, 3 nM, 5 nM, 21 nM, 20 nM, 9 nM, 6 nM, 20 nM, 2 nM, and 16 nM, respectively. Staurosporine (1 μM) induces >90% apoptosis in PC12 cells. Consistently, Staurosporine treatment induces a rapid and prolonged elevation of intracellular free calcium levels i, accumulation of mitochondrial reactive oxygen species (ROS), and subsequent mitochondrial dysfunction. The apoptosis of MCF7 cells induced by Staurosporine can be enhanced by the expression of functional caspase-3 via caspase-8 activation and Bid cleavage. Staurosporine treatment at 1 μM only partially inhibits IL-3-stimulated Bcl2 phosphorylation but completely blocks PKC-mediated Bcl2 phosphorylation. Staurosporine induces apoptosis of human foreskin fibroblasts AG-1518, depending on the lysosomal cathepsins D mediated cytochrome c release and caspase activation. In addition to activating the classical mitochondrial apoptosis pathway, Staurosporine triggers a novel intrinsic apoptosis pathway, relying on the activation of caspase-9 in the absence of Apaf-1. |
| In vivo(體內(nèi)研究) | In the gerbil and rat ischemia models, Staurosporine pretreatment (0.1-10 ng) before ischemia prevents neuronal damage in a dose-dependent manner, suggesting the involvement of PKC in CAl pyramidal cell death after ischemia. |
| 參考文獻 | |
| 參考文獻 | [1] Tamaoki T, et al. Biochem Biophys Res Commun, 1986, 135(2), 397-402. [2] Meggio F, et al. Eur J Biochem, 1995, 234(1), 317-322. [3] Kruman I, et al. J Neurosci Res, 1998, 51(3), 293-308. |
| 研究領域 | |
| 研究領域 | Cell CycleKinases/PhosphatasesCdks EpigeneticsCell cycleKinases/PhosphatasesCdks NeuroscienceNeurology processNeural Signal Transduction NeuroscienceNeurology processNeurodegenerative diseaseOther Drug DiscoverySmall Molecule DrugLead Compound Discovery |
10
化工儀器網(wǎng)